| Literature DB >> 33022864 |
Jiangjiexing Wu1, Yijun Yu2, Yuan Cheng1, Chaoqun Cheng1, Yihong Zhang1, Bo Jiang3, Xiaozhi Zhao3, Leiying Miao2, Hui Wei1,4.
Abstract
Glutathione peroxidase (GPx) plays an important role in maintaining the reactive oxygen metabolic balance, yet limited GPx-mimicking nanozymes are currently available for in vivo therapy. Herein, a ligand engineering strategy is developed to modulate the GPx-mimicking activity of a metal-organic framework (MOF) nanozyme. With different substituted ligands, the GPx-mimicking activities of MIL-47(V)-X (MIL stands for Materials of Institute Lavoisier; X=F, Br, NH2 , CH3 , OH, and H) MOFs are rationally regulated. With the best one as an example, both in vitro and in vivo experiments reveal the excellent antioxidation ability of MIL-47(V)-NH2 , which alleviates the inflammatory response effectively for both ear injury and colitis, and is more active than MIL-47(V). This study proves that high-performance GPx-mimicking nanozymes can be rationally designed by a ligand engineering strategy, and that structure-activity relationships can direct the in vivo therapy. This study enriches nanozyme research and expands the range of biomimetic MOFs.Entities:
Keywords: activity modulation; anti-inflammation therapy; glutathione peroxidase mimics; ligand engineering strategies; metal-organic frameworks
Mesh:
Substances:
Year: 2020 PMID: 33022864 DOI: 10.1002/anie.202010714
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336